These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 21616680)

  • 1. Costimulatory pathways in transplantation.
    Pilat N; Sayegh MH; Wekerle T
    Semin Immunol; 2011 Aug; 23(4):293-303. PubMed ID: 21616680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New look at therapeutic strategies for blocking costimulatory signal in experimental and pre-clinical transplantation.
    Ma A; Zhang L; Wang X; Chen H
    Curr Drug Saf; 2009 May; 4(2):155-66. PubMed ID: 19442109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulation Blockade in Transplantation.
    Yeung MY; Grimmig T; Sayegh MH
    Adv Exp Med Biol; 2019; 1189():267-312. PubMed ID: 31758538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of costimulatory molecules as targets for new immunosuppressives in transplantation.
    Kishimoto K; Dong VM; Sayegh MH
    Curr Opin Urol; 2000 Mar; 10(2):57-62. PubMed ID: 10785843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ transplantation: modulation of T-cell activation pathways initiated by cell surface receptors to suppress graft rejection.
    Weatherly K; Braun MY
    Methods Mol Biol; 2011; 677():419-30. PubMed ID: 20941624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
    van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
    J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation blockade: current perspectives and implications for therapy.
    Kinnear G; Jones ND; Wood KJ
    Transplantation; 2013 Feb; 95(4):527-35. PubMed ID: 23129000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.
    Turka LA; Linsley PS; Lin H; Brady W; Leiden JM; Wei RQ; Gibson ML; Zheng XG; Myrdal S; Gordon D
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):11102-5. PubMed ID: 1332070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell costimulation blockade and organ transplantation: a change of philosophy for transplant immunologists?
    Goldstein DR
    J Immunol; 2011 Mar; 186(5):2691-2. PubMed ID: 21325217
    [No Abstract]   [Full Text] [Related]  

  • 11. Translating costimulation blockade to the clinic: lessons learned from three pathways.
    Ford ML; Larsen CP
    Immunol Rev; 2009 May; 229(1):294-306. PubMed ID: 19426229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating T-cell costimulation as new immunosuppressive concept in organ transplantation.
    Pilat N; Schwarz C; Wekerle T
    Curr Opin Organ Transplant; 2012 Aug; 17(4):368-75. PubMed ID: 22790071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yin-Yang of costimulation: crucial controls of immune tolerance and function.
    Nurieva RI; Liu X; Dong C
    Immunol Rev; 2009 May; 229(1):88-100. PubMed ID: 19426216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals.
    Meyaard L; Kuiper H; Otto SA; Wolthers KC; van Lier RA; Miedema F
    Eur J Immunol; 1995 Jan; 25(1):232-7. PubMed ID: 7531146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Costimulatory Blockade to Induce Immune Tolerance in Liver Transplantation.
    Ding M; He Y; Zhang S; Guo W
    Front Immunol; 2021; 12():537079. PubMed ID: 33732228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell tolerance or function is determined by combinatorial costimulatory signals.
    Nurieva R; Thomas S; Nguyen T; Martin-Orozco N; Wang Y; Kaja MK; Yu XZ; Dong C
    EMBO J; 2006 Jun; 25(11):2623-33. PubMed ID: 16724117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Cyclosporine A and azathioprine on human T cells activated by different costimulatory signals.
    Leitner J; Drobits K; Pickl WF; Majdic O; Zlabinger G; Steinberger P
    Immunol Lett; 2011 Oct; 140(1-2):74-80. PubMed ID: 21756939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative feedback of T cell activation through inhibitory adapters and costimulatory receptors.
    Saito T; Yamasaki S
    Immunol Rev; 2003 Apr; 192():143-60. PubMed ID: 12670402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.